Literature DB >> 16314486

Analysis of orthologous gene expression between human pulmonary adenocarcinoma and a carcinogen-induced murine model.

Robert S Stearman1, Lori Dwyer-Nield, Laura Zerbe, Stacy A Blaine, Zeng Chan, Paul A Bunn, Gary L Johnson, Fred R Hirsch, Daniel T Merrick, Wilbur A Franklin, Anna E Baron, Robert L Keith, Raphael A Nemenoff, Alvin M Malkinson, Mark W Geraci.   

Abstract

Human adenocarcinoma (AC) is the most frequently diagnosed human lung cancer, and its absolute incidence is increasing dramatically. Compared to human lung AC, the A/J mouse-urethane model exhibits similar histological appearance and molecular changes. We examined the gene expression profiles of human and murine lung tissues (normal or AC) and compared the two species' datasets after aligning approximately 7500 orthologous genes. A list of 409 gene classifiers (P value <0.0001), common to both species (joint classifiers), showed significant, positive correlation in expression levels between the two species. A number of previously reported expression changes were recapitulated in both species, such as changes in glycolytic enzymes and cell-cycle proteins. Unexpectedly, joint classifiers in angiogenesis were uniformly down-regulated in tumor tissues. The eicosanoid pathway enzymes prostacyclin synthase (PGIS) and inducible prostaglandin E(2) synthase (PGES) were joint classifiers that showed opposite effects in lung AC (PGIS down-regulated; PGES up-regulated). Finally, tissue microarrays identified the same protein expression pattern for PGIS and PGES in 108 different non-small cell lung cancer biopsies, and the detection of PGIS had statistically significant prognostic value in patient survival. Thus, the A/J mouse-urethane model reflects significant molecular details of human lung AC, and comparison of changes in orthologous gene expression may provide novel insights into lung carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16314486      PMCID: PMC1613183          DOI: 10.1016/S0002-9440(10)61257-6

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  54 in total

1.  Comparative analysis of algorithms for signal quantitation from oligonucleotide microarrays.

Authors:  Yoseph Barash; Elinor Dehan; Meir Krupsky; Wilbur Franklin; Marc Geraci; Nir Friedman; Naftali Kaminski
Journal:  Bioinformatics       Date:  2004-01-29       Impact factor: 6.937

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis.

Authors:  P Yang; A G Schwartz; A E McAllister; G M Swanson; C E Aston
Journal:  Genet Epidemiol       Date:  1999-11       Impact factor: 2.135

4.  Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes.

Authors:  B Altenberg; K O Greulich
Journal:  Genomics       Date:  2004-12       Impact factor: 5.736

5.  Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses.

Authors:  A Bhattacharjee; W G Richards; J Staunton; C Li; S Monti; P Vasa; C Ladd; J Beheshti; R Bueno; M Gillette; M Loda; G Weber; E J Mark; E S Lander; W Wong; B E Johnson; T R Golub; D J Sugarbaker; M Meyerson
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-13       Impact factor: 11.205

6.  Atypical adenomatous hyperplasia of lung: its incidence and analysis of clinical, glycohistochemical and structural features including newly defined growth regulators and vascularization.

Authors:  Klaus Kayser; Johnson Obiefune Nwoye; Zdravko Kosjerina; Thorsten Goldmann; Ekkehard Vollmer; Herbert Kaltner; Sabine André; Hans-Joachim Gabius
Journal:  Lung Cancer       Date:  2003-11       Impact factor: 5.705

7.  Cluster analysis and display of genome-wide expression patterns.

Authors:  M B Eisen; P T Spellman; P O Brown; D Botstein
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

Review 8.  Chromosomal imbalances in human lung cancer.

Authors:  Binaifer R Balsara; Joseph R Testa
Journal:  Oncogene       Date:  2002-10-07       Impact factor: 9.867

9.  Altered expression of G1/S regulatory genes occurs early and frequently in lung carcinogenesis in transforming growth factor-beta1 heterozygous mice.

Authors:  Yang Kang; Laurent L Ozbun; Jerry Angdisen; Terry W Moody; Margaret Prentice; Bhalchandra A Diwan; Sonia B Jakowlew
Journal:  Carcinogenesis       Date:  2002-07       Impact factor: 4.944

Review 10.  The changing epidemiology of lung cancer in Europe.

Authors:  Maryska L G Janssen-Heijnen; Jan-Willem W Coebergh
Journal:  Lung Cancer       Date:  2003-09       Impact factor: 5.705

View more
  148 in total

1.  Oral iloprost improves endobronchial dysplasia in former smokers.

Authors:  Robert L Keith; Patrick J Blatchford; John Kittelson; John D Minna; Karen Kelly; Pierre P Massion; Wilbur A Franklin; Jenny Mao; David O Wilson; Daniel T Merrick; Fred R Hirsch; Timothy C Kennedy; Paul A Bunn; Mark W Geraci; York E Miller
Journal:  Cancer Prev Res (Phila)       Date:  2011-06

2.  The phosphoinositide 3-kinase regulatory subunit p85alpha can exert tumor suppressor properties through negative regulation of growth factor signaling.

Authors:  Cullen M Taniguchi; Jonathon Winnay; Tatsuya Kondo; Roderick T Bronson; Alexander R Guimaraes; José O Alemán; Ji Luo; Gregory Stephanopoulos; Ralph Weissleder; Lewis C Cantley; C Ronald Kahn
Journal:  Cancer Res       Date:  2010-06-08       Impact factor: 12.701

3.  Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.

Authors:  Robert L Keith; Vijaya Karoor; Anthony B Mozer; Tyler M Hudish; Mysan Le; York E Miller
Journal:  Lung Cancer       Date:  2010-01-29       Impact factor: 5.705

4.  Epigenetic inactivation of the potential tumor suppressor gene FOXF1 in breast cancer.

Authors:  Pang-Kuo Lo; Ji Shin Lee; Xiaohui Liang; Liangfeng Han; Tsuyoshi Mori; Mary Jo Fackler; Helen Sadik; Pedram Argani; Tej K Pandita; Saraswati Sukumar
Journal:  Cancer Res       Date:  2010-06-29       Impact factor: 12.701

5.  GPC5 gene and its related pathways in lung cancer.

Authors:  Yafei Li; Ping Yang
Journal:  J Thorac Oncol       Date:  2011-01       Impact factor: 15.609

6.  Prostacyclin prevents pulmonary endothelial cell apoptosis induced by cigarette smoke.

Authors:  S Patrick Nana-Sinkam; Jong Deog Lee; Sylk Sotto-Santiago; Robert S Stearman; Robert L Keith; Qamrul Choudhury; Carlyne Cool; Jane Parr; Mark D Moore; Todd M Bull; Norbert F Voelkel; Mark W Geraci
Journal:  Am J Respir Crit Care Med       Date:  2007-01-25       Impact factor: 21.405

7.  A gene expression signature associated with "K-Ras addiction" reveals regulators of EMT and tumor cell survival.

Authors:  Anurag Singh; Patricia Greninger; Daniel Rhodes; Louise Koopman; Sheila Violette; Nabeel Bardeesy; Jeff Settleman
Journal:  Cancer Cell       Date:  2009-06-02       Impact factor: 31.743

8.  A meta-analysis of lung cancer gene expression identifies PTK7 as a survival gene in lung adenocarcinoma.

Authors:  Ron Chen; Purvesh Khatri; Pawel K Mazur; Melanie Polin; Yanyan Zheng; Dedeepya Vaka; Chuong D Hoang; Joseph Shrager; Yue Xu; Silvestre Vicent; Atul J Butte; E Alejandro Sweet-Cordero
Journal:  Cancer Res       Date:  2014-03-20       Impact factor: 12.701

9.  Methods to increase reproducibility in differential gene expression via meta-analysis.

Authors:  Timothy E Sweeney; Winston A Haynes; Francesco Vallania; John P Ioannidis; Purvesh Khatri
Journal:  Nucleic Acids Res       Date:  2016-09-14       Impact factor: 16.971

Review 10.  HtrA serine proteases as potential therapeutic targets in cancer.

Authors:  Jeremy Chien; Mara Campioni; Viji Shridhar; Alfonso Baldi
Journal:  Curr Cancer Drug Targets       Date:  2009-06       Impact factor: 3.428

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.